{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"neuronal-ceroid-lipofuscinosis-9","columns":[{"gene":"","key":"population-f744ab77fb1421d50344","label":"Ceroid lipofuscinosis, neuronal, 9","mondoId":"MONDO:0012188","onsetQualifier":null,"originColumnKey":"MONDO:0012188/OMIM:609055","originalViews":[{"key":"MONDO:0012188/OMIM:609055","label":"Ceroid lipofuscinosis, neuronal, 9","scopeLabel":"OMIM:609055","sourceScope":"This column retains this exact native source population. It is not a pooled family estimate."}],"recordKeys":["016c543712eb9b2cc833c022d11c6c36cebc14b85b079ee5df99617dea35ef0a","08e7f2705b1c0d22bb6b3d194d5103d7263bf00757882f77201f55b983a2b547","11eb65e9ff2022c57fee06ef330b06b46c08950d3cd76dbaac085347ec2c61cb","139c8c5582a94fafd2347d4d808afcf19334e3022ad1fe97c7e93c7c950ed83d","4202c203c210d96366f07b974389788b7a60e4bdeb3ac05f01f718daabe5aeae","57b79609da1d7b98ecdc4299768c0e17209629cd63b73a77e81843fb4ad3bb19","642bb5ebf0c7af1dc5bb340c1d09843d1b2d70b9511d00817dff8bd21452a842","73863e5f4a262755f2996f12f0bea3e89a100c257ea7c730a4564401da963add","7c4d970a48fe295317a7caf5f9a558a643fdab8e0165df6430a01213aa365d2e","7eab9fda77dc4dc865e466f9e4a9428b37fb6c66477333cbb73cfef3f49c64c3","a9dcb0452abf6307bdf61c544f14bdc9477720b908e97630908264efb513ebf8","c2247ba0ad62553bd860fdecbcce89c3ec7f6081f5ec05fc6d68d9ff10e60167","e80a6bb9158cbeb7b9e8679380fd5e7248b473ac8fe03c12aed6145a58da984d","ea2036b78b17715b482993c18af24739542305e47293dc5742aa1b894f3570fe","f43ea3b112cfe037e02b7a8f0369f74e344fc7815585a9f34bfeb6a5f070babc","f6a4c26bc909a7034e7171893fbac6ba0bb8ea47477dde3b0dac7e613dd90697","fd7a0955361d5319c1a4de64d61c77fd96fa325ee85b5a8f03abd2d9693cf436"],"recordQualifiers":{},"scopeLabel":"OMIM:609055","sourceIds":["OMIM:609055"],"sourceScope":"This column retains this exact native source population. It is not a pooled family estimate."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f744ab77fb1421d50344"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001251","HP:0002059","HP:0003205","HP:0000654","HP:0001260","HP:0003208","HP:0001249"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"omim":17}},"features":[{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0003205","label":"Curvilinear intracellular accumulation of autofluorescent lipopigment storage material","primary":true},{"hpoId":"HP:0000654","label":"Decreased light- and dark-adapted electroretinogram amplitude","primary":true},{"hpoId":"HP:0001260","label":"Dysarthria","primary":true},{"hpoId":"HP:0003208","label":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","primary":true},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":true},{"hpoId":"HP:0002505","label":"Loss of ambulation","primary":false},{"hpoId":"HP:0002300","label":"Mutism","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000529","label":"Progressive visual loss","primary":false},{"hpoId":"HP:0002361","label":"Psychomotor deterioration","primary":false},{"hpoId":"HP:0002063","label":"Rigidity","primary":false},{"hpoId":"HP:0000510","label":"Rod-cone dystrophy","primary":false},{"hpoId":"HP:0002168","label":"Scanning speech","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001922","label":"Vacuolated lymphocytes","primary":false}],"ledeHtml":"Neuronal ceroid lipofuscinosis 9 (CLN9-NCL) is a rare condition that affects the nervous system. Symptoms may include loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (the loss of previously acquired skills). The underlying genetic cause of CLN9-NCL is unknown but it appears to be inherited in an autosomal recessive manner.","mondoId":"MONDO:0012188","node":{"canonicalSlug":"neuronal-ceroid-lipofuscinosis-9","comparisons":[{"documentSha256":"df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3","key":"expanded-cln","kind":"expanded","label":"CLN / Batten disease","memberIds":["MONDO:0008083","MONDO:0008767","MONDO:0008768","MONDO:0008769","MONDO:0009744","MONDO:0009745","MONDO:0010830","MONDO:0011144","MONDO:0012188","MONDO:0012391","MONDO:0012414","MONDO:0012588","MONDO:0012721","MONDO:0013866","MONDO:0014147","MONDO:0016295","MONDO:0017809","MONDO:0019260","MONDO:0019261","MONDO:0019262","MONDO:0030947","MONDO:0850001"],"mondoId":"MONDO:0016295","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-df7e5010cb40de30aba1.df7e5010cb40de30aba1b0d10ff00b9c8a49865234f6a0ea186c9a1493e9aae3.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Neuronal ceroid lipofuscinosis 9","originalSourceId":"ORPHA:228357","paragraphs":["Neuronal ceroid lipofuscinosis 9 (CLN9-NCL) is a rare condition that affects the nervous system. Symptoms may include loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (the loss of previously acquired skills). The underlying genetic cause of CLN9-NCL is unknown but it appears to be inherited in an autosomal recessive manner."],"rawAttribution":"MONDO:0012188","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:46Z","upstream":"GARD:0006618","url":"https://rarediseases.info.nih.gov/diseases/6618"},"ownColumnKeys":["population-f744ab77fb1421d50344"],"publication":"published","relationships":[{"kind":"parent","label":"juvenile neuronal ceroid lipofuscinosis","mondoId":"MONDO:0019262","slug":"juvenile-neuronal-ceroid-lipofuscinosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"016c543712eb9b2cc833c022d11c6c36cebc14b85b079ee5df99617dea35ef0a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003205","is_excluded":false,"label":"Curvilinear intracellular accumulation of autofluorescent lipopigment storage material","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"08e7f2705b1c0d22bb6b3d194d5103d7263bf00757882f77201f55b983a2b547","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002361","is_excluded":false,"label":"Psychomotor deterioration","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"11eb65e9ff2022c57fee06ef330b06b46c08950d3cd76dbaac085347ec2c61cb","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000654","is_excluded":false,"label":"Decreased light- and dark-adapted electroretinogram amplitude","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"139c8c5582a94fafd2347d4d808afcf19334e3022ad1fe97c7e93c7c950ed83d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4202c203c210d96366f07b974389788b7a60e4bdeb3ac05f01f718daabe5aeae","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002168","is_excluded":false,"label":"Scanning speech","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"57b79609da1d7b98ecdc4299768c0e17209629cd63b73a77e81843fb4ad3bb19","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003208","is_excluded":false,"label":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"642bb5ebf0c7af1dc5bb340c1d09843d1b2d70b9511d00817dff8bd21452a842","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"73863e5f4a262755f2996f12f0bea3e89a100c257ea7c730a4564401da963add","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7c4d970a48fe295317a7caf5f9a558a643fdab8e0165df6430a01213aa365d2e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002063","is_excluded":false,"label":"Rigidity","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7eab9fda77dc4dc865e466f9e4a9428b37fb6c66477333cbb73cfef3f49c64c3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a9dcb0452abf6307bdf61c544f14bdc9477720b908e97630908264efb513ebf8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002300","is_excluded":false,"label":"Mutism","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c2247ba0ad62553bd860fdecbcce89c3ec7f6081f5ec05fc6d68d9ff10e60167","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e80a6bb9158cbeb7b9e8679380fd5e7248b473ac8fe03c12aed6145a58da984d","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000529","is_excluded":false,"label":"Progressive visual loss","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ea2036b78b17715b482993c18af24739542305e47293dc5742aa1b894f3570fe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002505","is_excluded":false,"label":"Loss of ambulation","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f43ea3b112cfe037e02b7a8f0369f74e344fc7815585a9f34bfeb6a5f070babc","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001922","is_excluded":false,"label":"Vacuolated lymphocytes","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f6a4c26bc909a7034e7171893fbac6ba0bb8ea47477dde3b0dac7e613dd90697","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000510","is_excluded":false,"label":"Rod-cone dystrophy","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fd7a0955361d5319c1a4de64d61c77fd96fa325ee85b5a8f03abd2d9693cf436","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:609055","disease_name":"Ceroid lipofuscinosis, neuronal, 9","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:609055","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6618\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012188\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0006618</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Neuronal ceroid lipofuscinosis 9 (CLN9-NCL) is a rare condition that affects the nervous system. Symptoms may include loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (the loss of previously acquired skills). The underlying genetic cause of CLN9-NCL is unknown but it appears to be inherited in an autosomal recessive manner.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6618\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"neuronal-ceroid-lipofuscinosis-9","sourceDocuments":[{"name":"GARD: Neuronal ceroid lipofuscinosis 9","reviewed":null,"source_release":"2026-10-25T03:39:46Z","url":"https://rarediseases.info.nih.gov/diseases/6618"},{"name":"MONDO: neuronal ceroid lipofuscinosis 9","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012188"}],"sourceNote":"","synonyms":["ceroid lipofuscinosis, neuronal, 9","CLN 9","CLN9","neuronal ceroid lipofuscinosis type 9"],"takeawayHtml":"","title":"neuronal ceroid lipofuscinosis 9"},"schemaVersion":1}
